Introduction and Epidemiology
Oral and oropharyngeal squamous cell carcinoma (OSCC) is a heterogeneous group of malignancies that is documented worldwide due in part to the common use of tobacco and alcohol. Globally, approximately 400,000 cases are diagnosed annually with a mortality rate of over 223,000 (Ferlay et al. 2010). Furthermore, this group of head and neck cancers ranks among the top ten most common malignancies worldwide (Ferlay et al. 2010). According to 2012 US statistics, an estimated 40,000 new cancers of the oral cavity and pharynx will be diagnosed, and over 90 % of the cases will be SCC (Siegel et al. 2012). These cancers are estimated to represent over 2% of all malignancies in 2012, and approximately 7,850 individuals will die of this disease (Siegel et al. 2012). Of importance, there are significant changes in the incidence of OSCC depending upon the location. Alarming annual increases of 5% are observed in the oropharynx, in contrast to a decrease in oral cavity...
References
Ahn K, Chen CY, Hayes RB. Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Control. 2012;23:399–404.
Ang KK, Sturgis EM. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol. 2012;22:128–42.
Bebek G, Bennett KL, Funchain P, et al. Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinoma. Hum Mol Genet. 2012;21(7):1557–65.
Beutler B, Goodnow CC. How host defense is encoded in the mammalian genome. Mamm Genome. 2011;22(1–2):1–5.
Brown LM, Check DP, Devesa SS. Oropharyngeal cancer incidence trends: diminishing racial disparities. Cancer Causes Control. 2011;22:753–63.
Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–301.
de Villiers EM, Fauquet C, Broker TR. Classification of papillomaviruses. Virology. 2004;324(1):17–27.
Evans MF, Matthews A, Kandil D. Discrimination of ‘driver’ and ‘passenger’ HPV in tonsillar carcinomas by the polymerase chain reaction, chromogenic in situ hybridization, and p16(INK4a) immunohistochemistry. Head Neck Pathol. 2011;5(4):344–8.
Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.
Gillison ML. Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection. Curr Opin Oncol. 2009;21:439–44.
Hashibe M, Brennan P, Chuang S-C, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009;18(2):541–50.
Herrero R, Castellsague X, Pawlita M, Lissowska J, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95(23):1772–83.
Hooper SJ, Crean SJ, Fardy MA, et al. A molecular analysis of the bacteria present within oral squamous cell carcinoma. J Med Microbiol. 2007;56:1651–9.
Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck. 2009;31(9):1228–39.
Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975–2009 (Vintage 2009 populations). Bethesda: National Cancer Institute; 2012. http://seer.cancer.gov/csr/1975_2009_pops09/, based on Nov 2011 SEER data submission, posted to the SEER website.
Joly S, Compton LM, Pujol C, et al. Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. Oral Microbiol Immunol. 2009;24(5):353–60.
Kjaer SK, Sigurdsson K, Iversen OE, et al. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila). 2009;2(10):868–78.
Klingelhutz AJ, Roman A. Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses [Minireview]. Virology. 2012;424:77–98.
Kurago ZB, Lam-ubol A, Stetsenko A, et al. Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation. Head Neck Pathol. 2008;2:1–12.
Lam-ubol A, Hopkin D, Letuchy EM, Kurago ZB. Squamous carcinoma cells influence monocyte phenotype and suppress lipopolysaccharide-induced TNF-alpha in monocytes. Inflammation. 2010;33(4):207–23.
Mager DL, Haffajee AD, Devlin PM, et al. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med. 2005;3(1):27.
Marklund L, Hammarstedt L. Impact of HPV in oropharyngeal cancer. J Oncol. 2011;2011:509036.
McCullough M, Jaber M, Barrett AW, et al. Oral yeast carriage correlates with presence of oral epithelial dysplasia. Oral Oncol. 2002;38:391–3.
Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550–60.
Nagy KN, Sonkodi I, Szoke I, et al. The microflora associated with human oral carcinomas. Oral Oncol. 1998;34:304–8.
Paavonen J, Naud P, Salmeron J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374:301–14.
Pushalkar S, Mane SP, Ji X, et al. Microbial diversity in saliva of oral squamous cell carcinoma. FEMS Immunol Med Microbiol. 2011;61(3):269–77.
Russell JO, Hoschar AP, Scharpf J. Papillary squamous cell carcinoma of the head and neck: a clinicopathologic series. Am J Otolaryngol. 2011;32:557–63.
Sakamoto H, Sasaki J, Nord CE. Association between bacterial colonization on the tumor, bacterial translocation to the cervical lymph nodes and subsequent postoperative infection in patients with oral cancer. Clin Microbiol Infect. 1999;5:612–16.
Sasaki M, Yamaura C, Ohara-Nemoto Y, et al. Streptococcus anginosus infection in oral cancer and its infection route. Oral Dis. 2005;11:151–6.
Shiga K, Tateda M, Saijo S, et al. Presence of Streptococcus infection in extra-oropharyngeal head and neck squamous cell carcinoma and its implication in carcinogenesis. Oncol Rep. 2001;8:245–8.
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.
Stanley MA. Genital human papillomavirus infections: current and prospective therapies. J Gen Virol. 2012;93(pt 4):681–91.
Syrjänen K, Syrjänen S. Molecular biology of papillomaviruses. In: Syrjänen K, Syrjänen S, editors. Papillomavirus infections in human pathology. Chichester: Wiley; 2000. p. 11–52.
Syrjänen S, Lodi G, von Bultzingslowen I, et al. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis. 2011;17 Suppl 1:58–72.
Tezal M, Sullivan MA, Reid ME, et al. Chronic periodontitis and the risk of tongue cancer. Arch Otolaryngol Head Neck Surg. 2007;133(5):450–4.
Tezal M, Scannapieco FA, Wactawski-Wende J, et al. Local inflammation and human papillomavirus status of head and neck cancers. Arch Otolaryngol Head Neck Surg. 2012;138(7):669–75.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this entry
Cite this entry
Kurago, Z.B., Lam-ubol, A., Flaitz, C.M. (2013). Role of Microorganisms in Oral and Oropharyngeal Squamous Cell Carcinoma. In: Nelson, K. (eds) Encyclopedia of Metagenomics. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6418-1_61-11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6418-1_61-11
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-6418-1
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences